World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
53930
World Ranking
4331
National Ranking
236

Overview

Dieter Hoelzer is affiliated with Goethe University Frankfurt in Germany and has contributed significantly to research in the field of medicine, with a particular focus on hematology and related subfields. Their scholarly work spans public health, environmental and occupational health, pediatrics, perinatology, child health, pathology, forensic medicine, and pulmonary and respiratory medicine.

Their research topics concentrate on various aspects of blood cancers and their treatments, notably acute lymphoblastic leukemia (ALL), chronic myeloid leukemia, lymphoma diagnosis and treatment, CAR-T cell therapy, hematopoietic stem cell transplantation, and acute myeloid leukemia.

Recent notable publications include:

  • Management of ALL in adults: 2024 ELN recommendations from a European expert panel, 2024, Blood
  • Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel, 2024, Blood
  • Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussion, 2020, ESMO Open
  • Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial, 2020, Hematological Oncology
  • Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review, 2023, Leukemia & lymphoma/Leukemia and lymphoma

Their frequent co-authors include:

  • Nicola Gökbuget
  • Josep-María Ribera
  • Hagop M. Kantarjian
  • Pierre Fenaux
  • Nicolas Boissel

They have published extensively in several prominent journals, with frequent appearances in:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • ESMO Open
  • Hematological Oncology

Their body of work includes 35 publications categorized under medicine, with 10 focusing on hematology and an equivalent number addressing public health and occupational health. Research in pediatrics, perinatology, and child health accounts for 5 publications, while pathology, forensic medicine, and pulmonary and respiratory medicine are also represented. The main research topics show a strong emphasis on acute lymphoblastic leukemia research and chronic myeloid leukemia treatments, each with a substantial number of published works.

Best Publications

  • Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

    Birgit Assmus;Volker Schächinger;Claudius Teupe;Martina Britten

  • Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

    Mathias J Rummel;Norbert Niederle;Georg Maschmeyer;G Andre Banat

  • Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.

    Hagop M Kantarjian;Francis Giles;Lydia Wunderle;Kapil Bhalla

  • Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.

    Marion G Ott;Manfred Schmidt;Kerstin Schwarzwaelder;Stefan Stein

  • Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

    Max S. Topp;Peter Kufer;Nicola Gökbuget;Mariele Goebeler

  • Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

    Stefan Stein;Marion G. Ott;Stephan Schultze-Strasser;Anna Jauch

  • Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

    D Hoelzer;E Thiel;H Loffler;T Buchner

  • A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias

    Oliver G. Ottmann;Brian J. Druker;Charles L. Sawyers;John M. Goldman

  • Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

    Monika Brüggemann;Thorsten Raff;Thomas Flohr;Nicola Gökbuget

  • Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.

    Matthias Klinger;Christian Brandl;Gerhard Zugmaier;Youssef Hijazi

  • Modern Therapy of Acute Lymphoblastic Leukemia

    Renato Bassan;Dieter Hoelzer

  • Treatment of Adult Acute Lymphoblastic Leukemia

    Nicola Gökbuget;Dieter Hoelzer

  • Bendamustine Plus Rituximab Is Effective and Has a Favorable Toxicity Profile in the Treatment of Mantle Cell and Low-Grade Non-Hodgkin's Lymphoma

    Mathias J. Rummel;Salah E. Al-Batran;Soo-Z. Kim;Manfred Welslau

  • Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

    Max S. Topp;Nicola Gökbuget;Gerhard Zugmaier;Evelyn Degenhard

  • Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

    Nicola Gökbuget;Michael Kneba;Thorsten Raff;Heiko Trautmann

  • Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.

    Nicola Gökbuget;Daniel Stanze;Joachim Beck;Helmut Diedrich

  • Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia

    Felicitas Thol;Frederik Damm;Andrea Lüdeking;Claudia Winschel

  • Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph^+ALL)

    Barbara Wassmann;Heike Pfeifer;Nicola Goekbuget;Dietrich W. Beelen

  • High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome

    Lothar Bergmann;Cornelius Miething;Ulrich Maurer;Jürgen Brieger

  • Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008

    M. Bruggemann;A. Schrauder;T. Raff;H. Pfeifer

Frequent Co-Authors

Oliver G. Ottmann
Oliver G. Ottmann Cardiff University
Eckhard Thiel
Eckhard Thiel Charité - University Medicine Berlin
Arnold Ganser
Arnold Ganser Hannover Medical School
Hubert Serve
Hubert Serve Goethe University Frankfurt
Michael Kneba
Michael Kneba Kiel University
Michael Lübbert
Michael Lübbert University of Freiburg
Reinhard Seger
Reinhard Seger University of Zurich
Hervé Dombret
Hervé Dombret Université Paris Cité
Josep-Maria Ribera
Josep-Maria Ribera Autonomous University of Barcelona
Lothar Kanz
Lothar Kanz University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several related online degrees and career pathways that can accelerate your entry into healthcare. For experienced nurses aiming to advance, exploring dnp online programs can open opportunities in leadership and specialized clinical roles. Many of these programs offer flexible schedules and competitive durations, making it easier to balance work and study.

For those seeking more streamlined options, there are dnp programs without dissertation, allowing students to complete degree requirements without the extensive research commitment typically needed for traditional doctoral programs. Newcomers to nursing might be interested in the fast track lpn route, which provides essential training in a shorter time frame to quickly start working as a licensed practical nurse.

Another in-demand specialization is mental health. With online psych np programs, registered nurses can efficiently gain advanced skills to support mental health needs, a growing priority in healthcare today.

Best Scientists Citing Dieter Hoelzer

Trending Scientists

Recently Published Articles